St. David's Medical Center has become the first hospital in Central Texas to offer histotripsy, a new noninvasive treatment for liver cancer.

A new study from Japan has found that the risk of colorectal cancer (CRC) varies among different types of steatotic liver ...

A Chinese research team has developed an AI tool that predicts liver cancer recurrence risk with 82.2 percent accuracy, according to a study recently published in the journal Nature.

Discover the 5 ways alcohol progressively harms your liver, from early warning signs to serious complications, plus expert ...

Lehigh Valley Health Network’s Topper Cancer Institute has become the first in Pennsylvania to use histotripsy to treat ...

A novel strategy using lipid nanoparticles to reprogram liver immunity shows promise in generating antitumor responses ...

New research reveals distinct epidemiological trends in liver cancer across Mexico, with gender and regional variations ...

The scoring method, called the Tumor Immune Microenvironment Spatial System, or TIMES, is the first tool in the world to ...

A Chinese research team has developed an artificial intelligence (AI) tool that predicts liver cancer recurrence risk with 82 ...

Chinese scientists and their Singaporean collaborators have developed a scoring system to predict the risk of recurrence for ...